出处
《重庆医学》
CAS
CSCD
2005年第11期1721-1724,共4页
Chongqing medicine
基金
国家自然科学基金资助项目(30170424)
参考文献4
-
1刘志鹏,杨建民,陈文生.IGF-Ⅰ及IGF-Ⅱ受体反义基因对SMMC-7721肝癌细胞株增殖能力的影响[J].重庆医学,2002,31(3):195-197. 被引量:3
-
2Pei-YuanLi,Ju-ShengLin,Zuo-HuaFeng,Yu-FeiHe,He-JunZhou,XinMa,Xiao-KunCai,De-AnTian.Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma[J].World Journal of Gastroenterology,2004,10(15):2195-2200. 被引量:7
-
3张晨莉,邹冰,谭继宏,涂水平,马天乐,钟捷,孙璟,乔敏敏,江石湖.生存素反义核酸诱导肝癌细胞株SMMC-7721凋亡和增加其对抗肿瘤药物敏感性的研究[J].胃肠病学,2003,8(5):269-271. 被引量:7
-
4SongGu,Chang-JianLiu,TongQiao,Xue-MeiSun,Lei-LeiChen,LeZhang.Inhibitory effect of antisense vascular endothelial growth factor 165 eukaryotic expression vector on proliferation of hepatocellular carcinoma cells[J].World Journal of Gastroenterology,2004,10(4):535-539. 被引量:7
二级参考文献46
-
1Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
-
2Folkman J. Role of angiogenesis in tumor growth and metastasis.Semin Oncol 2002; 29(6 Suppl 16): 15-18.
-
3Bergers G, Hanahan D,Coussens LM. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis, Int J Dev Biol 1998; 42:995-1002.
-
4Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32:2534-2539.
-
5Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
-
6Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
-
7Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR.Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages,and tumors. Mol Biol Cell 1992; 3:211-220.
-
8Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S,Niknejad K, Peoples GE, Klagsbrun M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995; 55:4140-4145.
-
9Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
-
10Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997; 80:98-106.
共引文献19
-
1周莹冰,刘松青,唐敏.反义人血管生成素的真核表达载体的构建及其体外功能的初步研究[J].重庆医学,2004,33(10):1483-1485. 被引量:1
-
2陈涛,贾玉容,赵铁军,尹致良.survivin反义寡核苷酸对肝癌细胞生长抑制作用的研究[J].世界华人消化杂志,2004,12(7):1546-1549. 被引量:4
-
3邵成浩,胡先贵,刘瑞,张怡杰,唐岩,曹贵松.血管内皮生长因子反义核酸治疗裸鼠皮下种植胰腺癌[J].世界华人消化杂志,2004,12(12):2916-2918. 被引量:3
-
4蒋建伟,张洹.受体介导的c-myc反义核酸提高肝癌细胞对不同化疗药物的敏感性[J].中国肿瘤临床,2005,32(13):725-728. 被引量:3
-
5陆永伟,陈远能.靶向Survivin的肿瘤生物治疗[J].中国医学文摘(内科学),2006,27(1):18-20. 被引量:1
-
6陈华,郑军.肝癌的基因治疗[J].现代医药卫生,2006,22(5):679-681.
-
7陈远能.Survivin、NF-κB与肝癌的研究进展[J].中国医学文摘(内科学),2006,27(5):412-415.
-
8Ruben Hernandez-Alcoceba,Bruno Sangro,Jesus Prieto.Gene therapy of liver cancer[J].World Journal of Gastroenterology,2006,12(38):6085-6097. 被引量:6
-
9盛勤松,王琳,任锋,卢永刚,邹浩,肖曙峰,唐波,黄洁,张捷.pcDNA3/AFP/TK/Angio融合基因靶向性治疗人原发性肝癌的实验研究[J].中国普外基础与临床杂志,2007,14(4):403-408. 被引量:2
-
10崔云,刘文霞,李占全.Survivin与淋巴瘤的研究进展[J].新乡医学院学报,2007,24(6):636-639. 被引量:3
同被引文献33
-
1马军.三氧化二砷在白血病治疗中的临床应用[J].中国处方药,2004,3(10):17-20. 被引量:25
-
2袁涛,邓少丽,顾红光.肝细胞癌病人外周血AFP-mRNA含量与肝外转移间的关系研究[J].重庆医学,2005,34(11):1653-1654. 被引量:1
-
3陈翼,黄永火.原发性肝癌瘤内注射治疗进展[J].重庆医学,2005,34(11):1734-1736. 被引量:3
-
4Oketani M,Kohara K,Tuvdendroj D,et al.Inhibition by arsenic trioide of human hepatoma cell growth[J].Cancer Lett,2002,183 (2):147
-
5Salven P.Angiogenesis in lymphoproliferative disorders[J].Acta Haematol,2001,106(4):184
-
6Roboz GJ,Dias S,Lam G,et al.Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis[J].Blood,2000,96(4):1525
-
7Kwong YL,Todd D.Delicious poison:arsenic trioxide for the treatment of leukemia[J].Blood,1997,89(9):3487
-
8Thomas OF,Sherri Y,Edwin JI.Immunohistochemical evaluation of Bcl-2 gene family expression in liver hepatitis C and cirrhotic patients:a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics[J].Am J Gastroenterol,1999,94:178
-
9Kinjo K,Kizaki M,Muto A,et al.Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice[J].Leukemia,2000,14(3):431
-
10Cai X,Shen YL,Zhu Q,et al.Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia[J].Leukemia,2000,14(2):262
二级引证文献9
-
1蔡明,王国斌,陶凯雄,蔡昌学.三氧化二砷治疗肿瘤作用机制的研究现状及进展[J].重庆医学,2007,36(15):1534-1536. 被引量:2
-
2王强玉,王彦田(指导).砒石抑制肿瘤作用机制的研究进展[J].河北中医药学报,2008,23(2):43-45. 被引量:2
-
3应方微,唐松.三氧化二砷对人SO-Rb50瘤细胞在大鼠眼内生长及表达NGF/VEGF的影响[J].国际眼科杂志,2009,9(10):1868-1870.
-
4韩芳.中医药治疗原发性肝癌的研究进展[J].湖北中医学院学报,2010,12(2):63-65. 被引量:1
-
5应方微,唐松,刘桂琴.三氧化二砷对体外培养A375黑色素瘤细胞的生长抑制作用及机制初步研究[J].中国实用眼科杂志,2010,28(5):548-551. 被引量:1
-
6韩芳.中医药治疗原发性肝癌的研究进展[J].医学新知,2010,20(2):115-117. 被引量:2
-
7王磊,周荣耀,高月求.中医研究肝癌概况[J].中西医结合肝病杂志,2014,24(3):186-189. 被引量:9
-
8张卫华,刘思源,华长城.三氧化二砷对人骨肉瘤细胞MG-63增殖和凋亡的影响[J].健康研究,2020,40(2):184-187. 被引量:1
-
9任涛,王建俊,杨剑,杨鑫,徐浩,温贵兰,欧德渊.砷制剂对禽白血病肿瘤细胞Warburg效应及Hedgehog信号通路的影响[J].南方农业学报,2023,54(11):3349-3358.
-
1陈坛輈,黄智铭,周丽萍.肝细胞癌的基因免疫治疗[J].温州医学院学报,2005,35(4):342-343.
-
2何天霖,傅传刚.结直肠癌术后癌胚抗原基因疫苗辅助治疗的研究现状[J].中华胃肠外科杂志,2001,4(4):267-269. 被引量:4
-
3赵旭飞,沈岩.胰腺癌的综合治疗进展[J].国际外科学杂志,2006,33(3):185-189. 被引量:9
-
4兰英华,李用国,任红.甲胎蛋白与肝细胞癌[J].国际肿瘤学杂志,2004,31(S1):90-93.
-
5李刚,邓林.白细胞介素在人脑胶质瘤基因免疫治疗中的研究[J].中华神经外科疾病研究杂志,2009,8(5):385-388. 被引量:2
-
6叶敏,费哲为.胃癌的基因免疫治疗[J].实用医学杂志,2008,24(4):502-503. 被引量:1
-
7房良华,姜藻.肝癌的基因免疫治疗若干研究[J].东南大学学报(医学版),2005,24(5):351-354.
-
8孙永明,王海斌,胥正泉,田康松.白细胞介素-4修饰骨肉瘤SAOS-2细胞在SCID小鼠体内基因免疫治疗的研究[J].中华实验外科杂志,2009(9):1229-1229.
-
9王谨,李升平,郑利民.基因修饰T淋巴细胞在肿瘤免疫治疗中的应用[J].中国肿瘤生物治疗杂志,2008,15(3):292-295. 被引量:2
-
10范宝珍,毛宏胜,苏剑.胃肿瘤基因治疗研究[J].世界核心医学期刊文摘(眼科学分册),2003(4):735-737.